The Beauty Health Company

NASDAQ:SKIN

Household & Personal Products

Consumer Defensive
$12.46 +6.17%

+$0.04 today

Market cap
$81.18M
Beta
1.07
P/E (TTM)
-14.6
EPS (TTM)
-$0.05
52W Low $0.55High $2.69

Volume 0.05M

Average 0.95M

SKIN Accounts Payables

Cash effect of the change in amounts owed to suppliers; growing payables preserve cash.

The Beauty Health CompanyNASDAQ: SKIN

Accounts Payables · Q1 FY2026 · quarter ended Mar 2026

Accounts payables growth accelerates

Q1 FY2026 accounts payables of $9.6M (cash outflow) rose 67.5% year over year, ahead of the -52.5% change in trailing-twelve-month accounts payables. Sequentially, it rose 15383.9% from the prior quarter.

Context

  • Accounts payables amounted to 2.4% of revenue in FY2025, down 10.7 pp from a year earlier.
  • Accounts payables increased in 2 of the last 3 fiscal years.

What to watch

Whether quarterly growth of +67.5% holds above the trailing-twelve-month pace of -52.5%.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterMar 2026
-$9.6M+15383.9% QoQ
Last fiscal yearDec 2025
-$7.2M-83.6% YoY
LTMMar 2026
-$13.65M-52.5% YoY
Accounts Payables past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+67.5%——
1 year-83.6%——
3-year CAGR———
5-year CAGR——
10-year CAGR——

Accounts Payables history

USD · from the cash flow

Latest · FY2025
(7.2M) USD
Year-over-year change
+83.6%

Accounts Payables vs competitors

How SKIN compares with its peers on the latest reported figures

  • Peers report in different currencies, so accounts payables is compared through growth and share of revenue rather than absolute size.
  • Its year-over-year change of -52.5% is the 3rd highest of 7, against a peer median of -128.7%.
  • Accounts payables amounts to 4.6% of revenue for SKIN, versus a peer median of 0.7%.
SKIN Competitors
Accounts Payables for SKIN and competitors
Company Period LTM YoY 3-year CAGR% of revenue
SKINThe Beauty Health CompanyLTM Mar 2026$13.65M USD-52.5%—4.6%
SKILSkillsoft Corp.LTM Apr 2026$5.59M USD-177.2%—1.2%
SLSNSolesence, Inc. Common StockLTM Mar 2026$4.35M USD-309.6%—7.2%
YOULYoulife Group Inc.FY2025CN¥3.8M CNY+111.9%-38.6%0.2%
FTLFFitLife Brands, Inc.LTM Mar 2026$3.03M USD-331.8%+86.3%3.3%
ZVIAZevia PBCLTM Mar 2026$332K USD+106.4%—0.2%
ACUAcme United CorporationLTM Mar 2026$52.15K USD-80.1%—0.0%
Peer median (excluding SKIN) —-128.7%+23.8%0.7%

Competitors are the stored peer set for SKIN. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Cash Flow Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income(375.11M)44.38M(100.12M)(29.1M)(9.5M)
Depreciation & Amortization21.14M22.02M34.68M33.68M25.35M
Deferred Income Tax(3.76M)(1.79M)(1.08M)(3.75M)2.22M
Stock-Based Compensation12.42M28.5M22.54M26.7M14.82M
Change in Working Capital(18.66M)(140.28M)23.36M(27.39M)10.37M
Accounts Receivables(31.01M)(32.03M)12.85M20.8M8.59M
Inventory(9.44M)(82.1M)19.57M(10.5M)15.8M
Accounts Payables10.52M1.61M15.78M(43.78M)(7.2M)
Other Working Capital11.27M(27.77M)(24.85M)6.08M(6.83M)
Other Non-Cash Items335.62M(59.43M)41.29M16M36.63M
Operating Cash Flow(28.36M)(106.6M)21.75M16.13M37.5M
Capital Expenditures(15.62M)(17.39M)(13.05M)(6.79M)(303K)
Acquisitions (Net)(22.9M)(1.48M)(18.46M)00
Purchases of Investments00000
Sales of Investments00000
Other Investing Activities781K0000
Investing Cash Flow(37.73M)(18.87M)(31.51M)(6.79M)(5.16M)
Debt Repayment524.51M00(156.08M)(173.35M)
Common Stock Issued938.38M000(1.57M)
Common Stock Repurchased0(160M)(32.4M)(1.96M)0
Dividends Paid00000
Other Financing Activities(503.86M)(45.24M)(1.82M)(302K)26K
Financing Cash Flow959.04M(205.24M)(37.45M)(158.34M)(174.9M)
Effect of Forex Changes(543K)(2.98M)2.03M(3.96M)5.21M
Net Change in Cash892.4M(333.69M)(45.17M)(152.96M)(137.4M)
Free Cash Flow(43.98M)(123.99M)8.7M9.34M37.18M

The Beauty Health Company

NASDAQ:SKIN

Intrinsic Alpha fair value

Locked

Current Price

$12.46

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.